scholarly journals TCTAP C-237 Pressure Wire Measurement for an Intermediate Stenosis of Superficial Femoral Artery in a Patient with Intermittent Claudication

2016 ◽  
Vol 67 (16) ◽  
pp. S391-S392
Author(s):  
Naotaka Murata ◽  
Kou Hoshino ◽  
Kunihiro Sakoda ◽  
Jun Yamashita ◽  
Nobuhiro Tanaka
Keyword(s):  
Intermittent Claudication ◽  
Femoral Artery ◽  
Superficial Femoral Artery ◽  
Pressure Wire

scholarly journals Guidelines adherence or chronic total occlusion recanalization of the superficial femoral artery with a stentless approach: The next frontier?

2019 ◽  
Vol 7 ◽  
pp. 2050313X1882344
Author(s):  
Christos Rammos ◽  
Tobias Radecke ◽  
Julia Lortz ◽  
Martin Steinmetz ◽  
Tienush Rassaf
Keyword(s):  
Intermittent Claudication ◽  
Femoral Artery ◽  
Superficial Femoral Artery ◽  
Chronic Total Occlusion ◽  
Complication Rates ◽  
Total Occlusion ◽  
Chronic Total Occlusions ◽  
Surgical Bypass ◽  
Guidelines Adherence

In patients with intermittent claudication and long chronic total occlusions of the superficial femoral artery, a primary surgical bypass or stenting is recommended. However, due to the invasive nature, high complication rates and patient-related comorbidities, surgery is currently not the preferred method and full lesion stenting for long chronic total occlusions has the obvious consequences of permanent metallic implants. We report a case of a patient with a long chronic total occlusion of the superficial femoral artery with intermittent claudication. Endorsing an endovascular-first strategy, he was treated via an antegrade and retrograde approach with a complete recanalization and a stentless treatment with rotational atherectomy and drug-coated balloons. We believe this is a feasible endovascular strategy for the treatment of long chronic total occlusions of the superficial femoral artery for patients refusing open surgery. Further investigations are needed to evaluate long-term clinical outcomes of these novel techniques.

scholarly journals Results for primary bypass versus primary angioplasty/stent for intermittent claudication due to superficial femoral artery occlusive disease

2012 ◽  
Vol 55 (4) ◽  
pp. 1001-1007 ◽  
Author(s):  
Jeffrey J. Siracuse ◽  
Kristina A. Giles ◽  
Frank B. Pomposelli ◽  
Allen D. Hamdan ◽  
Mark C. Wyers ◽  
...  
Keyword(s):  
Intermittent Claudication ◽  
Femoral Artery ◽  
Superficial Femoral Artery ◽  
Primary Angioplasty ◽  
Occlusive Disease

Nutritional status and outcomes of superficial femoral artery stenting due to intermittent claudication

2020 ◽  
Vol 39 (2) ◽  
Author(s):  
Marta Spychalska-Zwolińska ◽  
Marzena Anaszewicz ◽  
Joanna Wiśniewska ◽  
Marcin Wasielewski ◽  
Artur Mieczkowski ◽  
...  
Keyword(s):  
Nutritional Status ◽  
Intermittent Claudication ◽  
Femoral Artery ◽  
Superficial Femoral Artery

scholarly journals Aneurysmal degeneration of fluoropolymer-coated paclitaxel-eluting stent in the superficial femoral artery: a rising concern

2021 ◽  
Vol 4 (1) ◽  
Author(s):  
Takuya Tsujimura ◽  
Osamu Iida ◽  
Mitsutoshi Asai ◽  
Masaharu Masuda ◽  
Shin Okamoto ◽  
...  
Keyword(s):  
Intermittent Claudication ◽  
Intravascular Ultrasound ◽  
Femoral Artery ◽  
Superficial Femoral Artery ◽  
Distal Part ◽  
De Novo ◽  
Vessel Diameter ◽  
Drug Eluting Stent ◽  
Drug Eluting ◽  
The Right

Abstract Background Although several clinical reports demonstrated a durable patency rate after a novel fluoropolymer-coated paclitaxel-eluting stent (Eluvia; Boston Scientific, Marlborough, MA, USA) placement, aneurysmal degeneration after drug-eluting stent (Eluvia) placement has raised clinical concerns. Here, we report a case with progressive aneurysm formation on serial angiography and intravascular ultrasound over 50 months after drug-eluting stent (Eluvia) placement for a superficial femoral artery atheromatous plaque. Case presentation A 79-year-old woman with right leg intermittent claudication at 100 m distance was referred to our hospital. Pre-procedural angiography showed long-segment severe stenosis from the middle-to-distal part of the right superficial femoral artery, and a 7 mm wide drug-eluting stent (Eluvia) was placed. However, the patient had a recurrence of intermittent claudication in the right lower extremity 25 months thereafter. Angiography revealed de novo stenosis in the distal part of the popliteal artery and proximal superficial femoral artery in-stent restenosis. Subsequently, the patient underwent endovascular therapy for these lesions. In addition, intravascular ultrasound at the time of endovascular therapy revealed femoral artery enlargement with a maximum vessel diameter of 10.0 mm at the distal edge of the stent. Intermittent claudication on the right side recurred again 50 months after drug-eluting stent (Eluvia). Angiography demonstrated de novo severe stenosis from the distal part of the superficial femoral artery to the middle part of the popliteal artery. Peri-stent contrast staining was found at the distal part of the drug-eluting stent (Eluvia) site. Intravascular ultrasound showed a further enlargement of maximum vessel diameter to 12.0 mm at the distal edge of the stent. Conclusions We report a case with progressive aneurysm degeneration on serial angiography and intravascular ultrasound over 50 months after drug-eluting stent (Eluvia) placement for a superficial femoral artery stenosis.

Proximal deep venous thrombosis following PTA of the superficial femoral artery – an obligation to disclose a complication that is rarely taken into account

VASA ◽  
2006 ◽  
Vol 35 (1) ◽  
pp. 41-44 ◽  
Author(s):  
Klein-Weigel ◽  
Pillokat ◽  
Klemens ◽  
Köning ◽  
Wolbergs ◽  
...  
Keyword(s):  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Femoral Artery ◽  
Superficial Femoral Artery ◽  
Rare Complication ◽  
Femoral Vein ◽  
Vein Thrombosis ◽  
Explicit Information ◽  
Life Threatening ◽  
Legal Consequences

We report two cases of femoral vein thrombosis after arterial PTA and subsequent pressure stasis. We discuss the legal consequences of these complications for information policies. Because venous thrombembolism following an arterial PTA might cause serious sequel or life threatening complications, there is a clear obligation for explicit information of the patients about this rare complication.

Sign in / Sign up

Export Citation Format

Share Document